Kennedy announces the complete termination of 22 mRNA vaccine development investments due to their ineffectiveness against upper respiratory infections like COVID-19 and influenza.
Kennedy announces the complete termination of 22 mRNA vaccine development investments due to their ineffectiveness against upper respiratory infections like COVID-19 and influenza.